When pancreatic islet allo-transplantation therapy was first introduced, it provided hope for countless diabetics tired of daily insulin injections. While the technology has delivered on much of its promise, Tel Aviv-based regenerative medicine firm Orgenesis is currently developing a treatment of its own, that it claims addresses much of the shortcomings of islet therapy. In a nutshell, its approach involves converting the patient’s own liver cells into cells that produce insulin... Continue Reading New diabetes treatment would turn liver cells into insulin-producers

Section: Health and Wellbeing

Tags: Diabetes, Insulin, Regenerative Medicine

Related Articles:




-->